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Salmonella Typhi, an exclusive human pathogen and
the cause of typhoid fever, expresses a functional cy-
tolethal distending toxin for which only the active
subunit, CdtB, has been identified. Here, we show
that PltA and PltB, which are encoded in the same
pathogenicity islet as cdtB, associate with CdtB to
form a multipartite toxin. PltA and PltB are homologs
of components of the pertussis toxin, including its
ADP-ribosyl transferase subunit. We also show that
PltA and PltB are required for the delivery of CdtB
from an intracellular compartment to target cells via
autocrine and paracrine pathways. We hypothesize
that this toxin, which we have named ‘‘typhoid toxin,’’
and its delivery mechanism may contribute to
S. Typhi’s unique virulence properties.
INTRODUCTION
Typhoid fever caused by Salmonella enterica serovar Typhi
(S. Typhi) results in 200,000 annual deaths world-wide, mostly
in developing countries where infections are endemic (Ivanoff
et al., 1994). Unlike other Salmonella enterica serovars, S. Typhi
can only infect humans, causing life-threatening systemic infec-
tions as well as persistent, often life-time colonization by estab-
lishing residence most commonly within the gall bladder (House
et al., 2001; Parry et al., 2002). Despite its public health impor-
tance, relatively little is known about the virulence factors that
confer on this bacterium its unique pathogenicity. Comparison
of the nucleotide sequence of the genome of S. Typhi with those
of other S. enterica serovars has shown the presence of an
unusually large number of pseudogenes in this human adapted
serovar (Deng et al., 2003; Edwards et al., 2002; Parkhill et al.,
2001). This observation has led to the proposal that the reduction
of its functional genome may be at least in part responsible for
S. Typhi’s narrow host range. Genome comparison has also re-
vealed the presence of a small number of putative virulence
genes that are unique to this serovar or that have very limited dis-
tribution among other S. enterica serovars and, therefore, may
contribute to its distinctive virulence properties. One of these
genes encodes CdtB, a homolog of the active or ‘‘A’’ subunit
of the cytolethal distending toxin (CDT) (Haghjoo and Gala´n,
2004). This toxin, which is present in several bacterial pathogens,
causes cell-cycle arrest and cellular distension because it inflicts30 Cell Host & Microbe 3, 30–38, January 2008 ª2008 Elsevier Inc.DNA damage on the intoxicated cells (Lara-Tejero and Gala´n,
2000, 2002). Unlike other bacteria that encode CDT, S. Typhi
does not encode homologs of the ‘‘B’’ subunits of CDT (i.e.,
CdtA and CdtC), which mediate toxin delivery into target cells.
However, S. typhi CdtB can induce DNA damage when it is tran-
siently expressed or microinjected into the cytosol of mammalian
cells (Haghjoo and Gala´n, 2004). More importantly, S. Typhi pos-
sesses cytolethal distending toxicity, and CdtB is delivered by an
unknown pathway that is strictly dependent on bacterial internal-
ization into host cells (Haghjoo and Gala´n, 2004). In fact, cdtB is
unusual in that it is only expressed by intracellularly localized
S. Typhi.
Here, we report that two proteins, PltA and PltB, which are
encoded within the same pathogenicity islet that carries cdtB,
exhibit amino acid sequence similarity to the pertussis toxin
‘‘A’’ subunit and one of the components of its heteropentameric
‘‘B’’ subunit, respectively. Like cdtB, expression of pltA and pltB
is induced intracellularly. Remarkably, we found that PltA and
PltB form a complex with CdtB and are required for cytolethal
distending toxicity by aiding the delivery of CdtB through auto-
crine and paracrine pathways.
RESULTS
S. Typhi Encodes Homologs of the Pertussis Toxin
that Are Expressed by Intracellular Bacteria
cdtB is encoded within a pathogenicity islet that is unique to
S. Typhi. Closer inspection of this islet revealed the presence
of two open reading frames capable of encoding polypeptides
with significant amino acid sequence similarity to the pertussis
toxin ADP-ribosylating ‘‘A’’ subunit and just one of the 5 compo-
nents of its heteropentameric ‘‘B’’ subunit (Kaslow and Burns,
1992) (we named these genes pltA and pltB for pertussis-like
toxin A and B, respectively) (Figure 1A and Figure S1 available
with this article online). Purified PltA was able to ADP-ribosylate
a protein in host cell lysates, although PltAE133A, a derivative
carrying a mutation in a residue predicted to be important for ca-
talysis, did not (Figure S2). These results suggest that PltA is an
active toxin. The absence of homologs of critical components of
the pertussis toxin B subunit was reminiscent of S. Typhi CDT,
which, as discussed above, also lacks the components of its B
subunit. Since cdtB is expressed only after bacterial internaliza-
tion into host cells (Haghjoo and Gala´n, 2004), we tested whether
pltA and pltB expression was also induced once S. Typhi
reached an intracellular compartment. We found low expression
of the pltBA operon when S. Typhi was grown in standard
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scription of pltBA was induced after infection of cultured intesti-
nal epithelial cells (Figure 1B). Consistent with this observation,
epitope-tagged PltB was not detected after up to 3 hr of infec-
tion of cultured intestinal epithelial cells (Figure 1C). However,
PltB was readily detected on the surface of intracellular bacteria
5 hr after infection of cultured intestinal cells (Figure 1C). Eight
hours after infection, staining in the form of puncta radiating
from the S. Typhi containing vacuole was also noticeable. By
24 hr of infection, the PltB-stained puncta, which we hypothesize
represent toxin that has left the bacteria-containing vacuole,
were readily seen throughout the cell (Figure 1C). Taken to-
gether, these results showed that, like cdtB, the expression of
pltA and pltB is induced within host cells and suggest that the
toxin can exit the bacteria-containing vacuole to localize in
puncta-like structures.
Figure 1. Expression and Delivery of the PltA/PltB
Toxin by Intracellular S. Typhi
(A) Diagram of the S. Typhi pathogenicity islet that encodes
CdtB, PltA, and PltB. The positions of the insertion sequences
(IS) that delineate the boundaries of this islet are indicated.
(B) Expression of pltA::luciferase reporter by S. Typhi at differ-
ent times during growth in LB broth or after infection of cul-
tured Henle-407 intestinal epithelial cells. Numbers represent
arbitrary units standardized by the number of bacteria and
considering the value obtained 6 hr after infection of cultured
cells to be 100. Values represent the mean ± standard devia-
tion of three independent determinations. The differences be-
tween the measurements in vitro at the time of infection and
6 hr after infection were statistically significant (p < 0.001).
(C) Immunofluorescence staining of cells infected with a strain
of S. Typhi that encodes a 33-FLAG epitope-tagged PltB.
Cells were infected and stained at different times postinfection
(as indicated) with a mouse monoclonal antibody specific for
the FLAG epitope (green) and a rabbit antibody specific for
S. Typhi (red) and DAPI (blue). Scale bar, 5 mm.
PltA and PltB Are Required for CdtB Toxicity
To investigate the potential role of PltA/PltB in
S. Typhi host-cell interactions, we infected cultured
intestinal epithelial cells with a DpltA or a DpltB
S. Typhi mutant strain. Surprisingly, cells infected
with either of these mutants did not show the typical
signs of cytolethal distending intoxication associ-
ated with CdtB, such as cytoplasmic distension
and cell-cycle arrest (Figure 2). The toxicity of the
DpltA or the DpltB strains was recovered when
the mutants were complemented with plasmids en-
coding wild-type alleles of these genes. Impor-
tantly, a plasmid encoding the catalytic mutant
PltAE133A was also able to complement the pheno-
type of the DpltA mutant strain, indicating that the
catalytic activity of PltA is not required for its contri-
bution to the CdtB-dependent toxicity. Taken to-
gether, these results demonstrate a functional rela-
tionship between the CdtB and PltA/PltB toxins,
although such relationship does not involve the en-
zymatic activity of PltA. Consequently, these re-
sults suggest that CdtB may require PltA/PltB for
its secretion and/or delivery into target cells, per-
haps because these proteins are recognized as a complex by
the machineries involved in either of these processes.
PltA and PltB Are Required for CdtB
Delivery from an Intracellular Compartment
We tested the hypothesis that PltA and PltB are required for CdtB
secretion from the bacterial cell. Indeed, other multisubunit
toxins, such as pertussis toxin, are known to require specific se-
cretion systems to export the folded and assembled toxin from
the bacterial periplasm to the extracellular space (Burns, 2003;
Farizo et al., 2000). However, this does not seem to be the
case since equivalent levels of CdtB were found in detergent-
soluble lysates (which represent the secreted fraction of the
toxin) of cells infected with either wild-type or the DpltA or DpltB
mutants, although CdtBD1-22, a mutant lacking the predicted sec
secretion signal, was not found in the lysates (Figure 3A). WeCell Host & Microbe 3, 30–38, January 2008 ª2008 Elsevier Inc. 31
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type and the DpltA or DpltB mutant strains. Cells infected with
wild-type bacteria showed a CdtB-staining pattern indistinguish-
able from that observed with PltB: no staining at early (up to 3 hr)
times of infection, prominent bacterially-associated staining at
5 hr after infection, and staining in the form of puncta radiating
from the bacteria-containing vacuole at 5 hr and 8 hr of infection
and throughout the cell after 24 hr of infection (Figure 3B). Differ-
ential staining, confocal microscopy, and protease susceptibility
experiments indicated that the CdtB puncta were located mostly
within the cell (Figure 3C and Figure S3 and S4). CdtB that was
not associated with bacteria (and therefore representing the
fraction already secreted from the bacteria) could be detected
in a compartment with a buoyant density of z1.15 g cm3
(equivalent to 35% sucrose) and was resistant to protease (un-
less in the presence of Triton X-100) (Figure S5). These results
suggest that a significant proportion of this fraction of CdtB
was contained within a membrane-bound compartment. In con-
trast, cells infected with the DpltA or DpltB mutant strains
showed CdtB staining in association with the bacterial surface
Figure 2. PltA and PltB Are Required for CdtB Toxicity
Effect of DpltA and DpltB on cytolethal distending toxicity. Henle-407 cells
were infected with different S. Typhi strains as indicated, and 72 hr after infec-
tion, the cells were examined by phase contrast microscopy (insets) or
processed to measure DNA content by flow cytometry as described in the Ex-
perimental Procedures. The peaks corresponding to cells in G0-G1, S, or G2
are indicated. Equivalent results were obtained in several repetitions of the
same experiment. Scale bars, 50 mm.32 Cell Host & Microbe 3, 30–38, January 2008 ª2008 Elsevier Inc.but never associated with puncta, even after 24 hr of infection
(Figure 3D). The distribution of CdtB in puncta throughout the
cell was restored upon introduction of a plasmid encoding pltBA
(Figure 3D). These results indicate that the lack of cytolethal
distending toxicity in the DpltA or DpltB mutants is not due to
a defect in CdtB secretion from the bacteria but presumably
from its failure to exit the Salmonella-containing vacuole and
reach its place of action.
CdtB, PltA, and PltB Form a Complex
In Vitro and Colocalize within Host Cells
The functional relationship between PltA, PltB, and CdtB sug-
gested the possibility that these proteins form a complex that
may be required for the delivery of CdtB to its place of action.
We, therefore, tested whether PltA, PltB, and CdtB could form
a complex in vitro. Polyhistidine-tagged versions of these pro-
teins were expressed in E. coli, purified from inclusion bodies,
refolded in vitro, and tested for their ability to form a complex
by gel filtration or ion exchange chromatography. When refolded
together and applied to a gel filtration column, PltA and PltB
eluted with a profile that indicated the formation of a complex
(Figure 4A). The ability of CdtB to interact with the PltA/PltB
complex was tested by ion exchange chromatography. When
applied by itself to a MonoQ ion exchange column, CdtB was
not retained and was recovered in the flow-through fraction
(Figure 4B). Under the same running conditions, the PltA/PltB
complex was retained in the MonoQ column (data not shown).
Addition of CdtB to the PltA/PltB complex resulted in the reten-
tion of CdtB in the column, indicating that the three proteins form
a complex (Figure 4B). We then tested whether CdtB colocalizes
with PltA/PltB during bacterial infection. Henle-407 cells were in-
fected with a S. Typhi strain encoding 33-FLAG epitope-tagged
PltB and a 33-Myc epitope-tagged CdtB, and the localization of
these proteins was investigated by fluorescence microscopy. As
shown in Figure 4C, CdtB and PltB colocalized both on the bac-
terial surface and in puncta throughout the cell. Taken together,
these results indicate that, consistent with their functional rela-
tionship, CdtB forms a complex with PltA and PltB and traffics
through the cell presumably in association with these proteins.
CdtB Is Exported to the Extracellular Medium
in a PltA/PltB-Dependent Fashion
We found that infection of cultured epithelial cells with S. Typhi
resulted in cytolethal distending intoxication of virtually all cells
despite the fact that only a fraction of the cells were actually
infected. This observation suggested the possibility that CdtB
is transported to the culture medium, intoxicating cells in a para-
crine fashion. We, therefore, examined whether CdtB toxic activ-
ity could be detected in the culture medium of infected cells.
Cells were infected with wild-type S. Typhi, and 24 hr after infec-
tion, the presence of cytolethal distending activity in the bacte-
ria-free culture medium was examined by applying cell culture
supernatant filtrates to uninfected cells. Cells that were treated
with a culture filtrate of cells that had been infected with wild-
type S. Typhi showed clear signs of intoxication such as cellular
distension and cell-cycle arrest (Figure 5). In contrast, cells
treated with a culture filtrate obtained from cells infected with
the S. Typhi DpltA, DpltB, or DcdtB mutant strains showed no
signs of toxicity (Figure 5). Consistent with the presence of toxin
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CdtB Delivery from an Intracellular Com-
partment
(A) Production and secretion of CdtB is not af-
fected in the pltA or pltB mutant strains. Henle-
407 cells were infected with wild-type S. Typhi
or its isogenicDpltA orDpltB mutants, all express-
ing either a 33-FLAG-tagged CdtB or 33-FLAG
CdtBD1-22 (as a control for a nonsecreted protein),
and 24 hr after infection, cells were detached from
the plate and lysed as described in Experimental
Procedures. Lysates were centrifuged 5 min at
20,000 3 g, and the supernatants were filtered
through a 0.2 mm filter. Filtered supernatants (rep-
resenting the secreted fraction) and pellets (repre-
senting the bacterially associated fraction) were
analyzed by western immunoblotting with an anti-
body directed to the FLAG tag. The blot corre-
sponding to the experiment with the strain
expressing 33-FLAG CdtB was reprobed with an
antibody to the intracellular protein RecA (lower
panel).
(B) Immunofluorescence staining of cells infected
with a strain of S. Typhi that encodes a 33-FLAG
epitope-tagged CdtB. Henle-407 cells were in-
fected with a wild-type strain of S. Typhi encoding
33-FLAG epitope-tagged CdtB, and at different
times after infection, cells were stained with
a mouse monoclonal antibody directed to the
FLAG epitope (green) and a rabbit antibody di-
rected to S. Typhi (red) and DAPI (blue). Scale
bar, 5 mm.
(C) Distribution of CdtB within infected cells after
S. Typhi infection examined by differential stain-
ing. Cells were infected with a wild-type strain of
S. Typhi expressing a chromosomally encoded
33-FLAG epitope-tagged CdtB. Twenty-four hours
after infection, cells were fixed with 4% parafor-
maldehyde and subjected to a differential staining
protocol to distinguish extracellular from intracellular CdtB. Briefly, fixed cells were stained with a rabbit antibody directed to CdtB. Cells were permeabilized with
0.3% Triton X-100, stained with a mouse monoclonal antibody directed to the FLAG epitope, and subsequently stained with Alexa 594-labeled anti-rabbit (out-
side, red) and Alexa 488-labeled anti-mouse (inside, green) IgG antibodies and DAPI to visualize DNA (blue). Cells were observed under a fluorescence micro-
scope. Scale bar, 5 mm.
(D) Effect of DpltA and DpltB on the localization of CdtB after bacterial infection. Henle-407 cells were infected with a wild-type strain of S. Typhi or the mutant
DpltA or DpltB derivatives and the corresponding complemented strains, all encoding 33-FLAG epitope-tagged CdtB. Twenty-four hours after infection, cells
were stained with a mouse monoclonal antibody directed to the FLAG epitope (green) and a rabbit antibody directed to S. Typhi and visualized under a fluores-
cence microscope. Scale bar, 5 mm.activity in the infection medium, both CdtB and PltB were de-
tected by western blot analysis of filtrates obtained from infected
cells (Figure S6). The presence of the toxin in the cultured super-
natant was not likely due to lysis of the infected cells since the
total number of cells and, more specifically, the number of in-
fected cells did not change over the course of the experiment
(Figure S7). Furthermore, the amount of toxic activity recovered
from cell culture supernatants could not have originated from the
very small number of cells that could have lysed and escaped
detection with our assays. In addition, toxicity of the DpltA
mutant was not rescued by the addition of purified PltA to the in-
fection medium (Figure S8) and, as shown above, CdtB did not
appear in puncta in cells infected with the DpltA or DpltB mutant
strains (see Figure 3D). Taken together, these results indicate
that CdtB is transported from its site of production within the
host cell to the extracellular medium and that PltA and PltB are
essential for this transport.CdtB Intoxicates Cells via Autocrine
and Paracrine Delivery Pathways
The presence of CdtB-dependent cytolethal distending toxicity
in the culture medium suggested the presence of a potential
paracrine mechanism by which the exported toxin may intoxi-
cate uninfected neighboring cells or may even reach systemic
sites to intoxicate cells from other tissues. To investigate this
possibility, we infected cells with wild-typeS. Typhi at a multiplic-
ity of infections such that only 60% of the cells were infected.
Subsequent to infection, we added a toxin-neutralizing antibody,
and at 48 hr postinfection, we examined cells for signs of cytole-
thal distending intoxication. Addition of the neutralizing antibody
completely blocked the distension and cell-cycle arrest of unin-
fected cells. Surprisingly, however, addition of the neutralizing
antibody also blocked the distension and cell-cycle arrest of in-
fected cells (Figure 6A) as well as the ability of CdtB to induce
DNA damage (as measured by the detection of phosphorylatedCell Host & Microbe 3, 30–38, January 2008 ª2008 Elsevier Inc. 33
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plex In Vitro and Colocalized within Host
Cells
(A) PltA interacts with PltB. PltA and PltB purified
from inclusion bodies were refolded and run on
a Superdex 75 HR gel filtration column. Fractions
were collected and separated by SDS-PAGE,
and proteins were stained by Coomassie brilliant
blue (shown in lower panel). Upper panel shows
the elution profile of the column.
(B) CdtB forms a complex with PltA and PltB. PltA,
PltB, and CdtB (blue trace) or CdtB alone (red
trace) were loaded onto an ion exchange chroma-
tography MonoQ column, and bound proteins
were eluted with a 20 ml linear gradient of 0 to
500 mM NaCl in the same sample buffer at
a flow rate of 1 ml/min. Fractions were collected,
separated by SDS-PAGE, and proteins were
stained by Coomassie brilliant blue (shown in
lower panel). The inset shows the input and flow
through material when the MonoQ column was
loaded with CdtB alone, which, under these condi-
tions, does not bind the column (see Experimental
Procedures for details).
(C) CdtB colocalizeswithPltBduringbacterial infection. Henle-407 cellswere infectedwith a strain ofS.Typhi encoding33-FLAGepitope-taggedPltB and a 33-Myc
epitope-tagged CdtB. Twenty-four hours after infection, cells were stained with a mouse monoclonal antibody directed to the FLAG epitope (green), a rabbit poly-
clonal antibody to the Myc epitope (red), and DAPI to stain the bacterial DNA (blue). Stained cells were observed under a fluorescence microscope. Scale bar, 5 mm.histone H2AX in the nucleus of infected cells; Lowndes and Toh,
2005) (Figure 6B). However, the presence of the CdtB-associ-
ated puncta in infected cells was not affected by the addition
of the neutralizing antibody (Figure 6C), indicating that addition
Figure 5. CdtB Is Exported to the Extracellular Medium in a PltA/
PltB-Dependent Manner
Cell culture supernatant contains cytolethal distending toxic activity. Henle-
407 cells were infected with wild-type S. Typhi or its isogenic cdtB, pltA, or
pltB mutant derivatives, and 24 hr after infection, culture supernatants were
removed, filtered, and applied to uninfected Henle-407 cells. Thirty hours after
application of the different culture supernatants, the cells were examined by
phase-contrast microscopy (insets) and processed to measure DNA content
by flow cytometry as indicated in the Experimental Procedures. The peaks cor-
responding to cells in G0-G1, S, or G2 are indicated. Equivalent results were
obtained in several repetitions of the same experiment. Scale bar, 50 mm.34 Cell Host & Microbe 3, 30–38, January 2008 ª2008 Elsevier Inc.of the antibody did not block the production and intracellular
transport of the CdtB toxin. These results indicate that the auto-
crine and paracrine pathways are presumably the only mecha-
nisms of delivery of CdtB into cells, and argue against a mecha-
nism of delivery from the Salmonella-containing vacuole to the
site of action in the nucleus without an extracellular stage.
Exogenous Addition of Purified CdtB/PltA/PltB
Complex Results in CDT Toxicity
Deletion of pltA or pltB resulted in lack of CdtB puncta through-
out the infected cell and absence of CdtB-dependent toxicity in
the culture medium of infected cells (see Figure 3D and Figure 5).
These results implicated PltA and PltB in the export of CdtB from
the Salmonella-containing vacuole but did not address the
potential role of these proteins in the delivery of CdtB from the
extracellular location. To address the potential role of PltA and
PltB in the delivery of CdtB via the autocrine and paracrine path-
ways, we tested the toxicity of purified CdtB alone or in complex
with purified PltA, PltB, or both. Addition of CdtB alone or in
combination with only PltA or PltB did not result in any detect-
able cytolethal distending toxicity (Figure 7A). In contrast, cells
treated with a combination of the three proteins showed promi-
nent distension and cell-cycle arrest, which are the characteristic
signs of cytolethal distending intoxication (Figure 7A). These
results indicate that PltA and PltB are required for the delivery
of CdtB into target cells after its export from the toxin-producing
infected cell.
DISCUSSION
Symbiotic and pathogenic bacteria that have sustained a pro-
longed association with their hosts have evolved very complex
functional interfaces. Often, central to the shaping of these func-
tional interfaces are bacterial proteins that have the capacity to
Cell Host & Microbe
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curs through PltA/PltB-Dependent Auto-
crine and Paracrine Delivery Pathways
(A) Exogenousapplication of a CdtB-neutralizing an-
tibody inhibitsCdtB-mediated intoxicationafterbac-
terial infection. Henle-407 cells were infected with
wild-type S. Typhi or a cdtB mutant (as a control),
and 4 hr after infection, CdtB neutralizing antibody
or the preimmune serum were added. Fifty-two
hours after infection, the cells were examined by
phase-contrast microscopy (insets) and processed
to measure DNA content by flow cytometry as indi-
cated in the Experimental Procedures. The peaks
corresponding to cells in G0-G1, S, or G2 are indi-
cated. Equivalent results were obtained in several
repetitions of this experiment. Scale bar, 50 mm.
(B) Exogenous application of a CdtB-neutralizing antibody inhibits CdtB-mediated DNA damage. Henle-407 cells were infected with wild-type S. Typhi or a cdtB
mutant in the presence or absence of a CdtB neutralizing antibody, and 30 hr after infection, cells were stained with a mouse monoclonal antibody directed to
phosphorylated histone H2AX (green) to identify foci of DNA damage, a rabbit polyclonal antibody toS. Typhi (red), and DAPI (blue) to stain DNA. Scale bar, 20 mm.
(C) Exogenous application of a CdtB-neutralizing antibody does not alter the intracellular distribution of CdtB. Henle-407 cells were infected with a S. Typhi strain
encoding 33-FLAG epitope-tagged CdtB, and 4 hr after infection, CdtB neutralizing antibody or the preimmune serum (as indicated) were added. Twenty-four
hours after infection, cells were stained with a mouse monoclonal antibody directed to the FLAG epitope (green), a rabbit antibody directed to S. Typhi (red), and
DAPI (blue) to stain DNA. Scale bar, 5 mm.modulate cellular functions, such as cytoskeleton dynamics, ve-
sicular trafficking, cell-cycle progression, and innate immune re-
sponses. Bacteria have evolved a variety of strategies to deliver
those proteins to their site of action. In the simplest form, thebacterial proteins or toxins have, in their primary amino acid se-
quence, all the information necessary not only to modulate cellu-
lar functions but also to reach their destination within the target
cell (Just and Gerhard, 2004). In other instances, the help ofFigure 7. Exogenous Addition of the CdtB/PltA/PltB
Complex Results in Cytolethal Distending Toxicity
(A) Henle-407 cells were treated with 1 mg/ml total protein of
purified CdtB, PltA, or PltB in different combinations as indi-
cated, and 72 hr after treatment, the cells were examined
under a phase microscope (insets) or processed to measure
DNA content by flow cytometry as indicated in the Experimen-
tal Procedures. The peaks corresponding to cells in G0-G1, S,
or G2 are indicated. Equivalent results were obtained in sev-
eral repetitions of the same experiment. Coomassie-blue-
stained SDS-PAGE of the preparations used in these studies
are shown in each panel.
(B) Model for CdtB/PltA/PltB toxin delivery. After internalization
(I), S. Typhi reaches a compartment where expression of cdtB,
pltA, and pltB can take place (II). The CdtB/PltA/PltB complex
is secreted from the bacteria into the lumen of the S. Typhi-
containing vacuole, and it is recognized and packaged into
transport carriers (III). The complex is then transported to the
plasma membrane and secreted to the extracellular medium
(IV) from where it can target susceptible noninfected cells
(e.g., cells of the immune system) and induce DNA damage
(V). Infected cells that do not express a receptor for the toxin
would be resistant to the toxin and provide a safe haven for
the bacteria (IV and V).Cell Host & Microbe 3, 30–38, January 2008 ª2008 Elsevier Inc. 35
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deliver the enzymatically active bacterial protein (i.e., the ‘‘A’’ sub-
unit) into the appropriate target cell (Alouf, 2000). Other delivery
mechanisms utilize complex multiprotein machines (e.g., type III
and type IV protein secretion systems) to deliver groups of bacte-
rial proteins to the appropriate target cell in a temporally and spa-
tially coordinated manner (Cascales and Christie, 2003; Gala´n and
Wolf-Watz,2006).Here, wehavedescribed a mechanism thatmay
help an intracellular pathogen to deliver a toxin to systemic sites.
We have previously reported that S. Typhi encodes the ‘‘A’’
subunit homolog of the cytolethal distending toxin (CDT) but
does not encode homologs of the ‘‘B’’ subunit components
(Haghjoo and Gala´n, 2004). We also showed that cytolethal dis-
tending intoxication requires bacterial internalization into host
cells. We have described here that in the same pathogenicity is-
let, S. Typhi also encodes an active ADP-ribosyl transferase that
is a homolog of the pertussis toxin ADP-ribosylating ‘‘A’’ subunit
(PltA). Interestingly, S. Typhi encodes just one homolog (PltB) of
the five components of pertussis toxin heteropentameric ‘‘B’’
subunit. The presence of an ‘‘A’’ subunit homolog of a toxin
with the absence of ‘‘B’’ subunit counterparts is reminiscent of
S. Typhi CDT, which as discussed above, lacks homologs of
its ‘‘B’’ subunit. Remarkably, we found that PltA/PltB is required
for CdtB-mediated toxicity. Our studies indicate that such a role
is independent of the enzymatic activity of PltA since a catalytic
mutant of this toxin was competent for the delivery of CdtB.
Rather, our results suggest that CdtB must associate with
PltA/PltB to be engaged by the cellular transport machinery
that eventually delivers this complex to the extracellular medium,
presumably in a common transport carrier. Remarkably, we
found that transport to the extracellular space is essential for
CdtB intoxication, which occurs exclusively through autocrine
or paracrine pathways. These conclusions are supported by
the following observations: (A) CdtB colocalizes with PltA/PltB
in structures visualized as puncta by immunofluorescence, (B)
CdtB-associated puncta most likely represent vesicles since
they have a measurable buoyant density and can protect CdtB
from protease treatment unless in the presence of detergent,
(C) CdtB, its associated cytolethal distending toxicity, and
PltA/B are found in the extracellular medium of infected epithelial
cells, (D) addition of a neutralizing antibody effectively blocks
toxicity both in infected and uninfected cells, and (E) in the
absence of pltA or pltB, there is no CdtB-associated toxicity,
no CdtB-associated puncta within cells, and no toxicity in the
extracellular medium.
We also found that both PltA and PltB are essential for CdtB
delivery from the extracellular space since the CdtB/PltA/PltB
complex, but not CdtB alone or in combination with either PltA
or PltB, was readily toxic when added exogenously. Addition
of the CdtB/PltA/PltB complex, however, did not lead to the de-
tection of toxin-containing puncta in intoxicated cells (data not
shown), suggesting that the CdtB/PltA/PltB-associated puncta
represent ‘‘outgoing’’ (i.e., on its way to the extracellular medium)
but not ‘‘incoming’’ (i.e., coming from the extracellular space)
toxin. Consistent with this hypothesis, addition of the neutralizing
antibody did not block the formation of toxin-associated puncta,
although it completely blocked intoxication.
In essence, CdtB/PltA/PltB constitutes a tripartite exotoxin
that we have named ‘‘typhoid toxin.’’ This toxin has two distinct36 Cell Host & Microbe 3, 30–38, January 2008 ª2008 Elsevier Inc.biochemical activities, a DNAse activity associated with CdtB
and an ADP-ribosylating activity associated with PltA. We
hypothesize that evolution may have reshaped what may have
originally been two independent toxins to combine them into
one single tripartite toxin that is suited for its delivery from an
intracellular location, and hence adapted to the biology of an in-
tracellular pathogen. According to the model suggested by our
results (Figure 7B), after synthesis by intracellular bacteria, this
toxin is subsequently exported to the extracellular space from
where, in an autocrine and paracrine fashion, it can intoxicate
not only bacterially-infected cells but also neighboring cells or
even cells at systemic sites if transported to such locations.
What advantages might this unusual delivery pathway confer
to S. Typhi? Unlike other S. enterica serovars, S. Typhi is known
to persistently infect humans for extended periods of time and, if
untreated, potentially for life. It is thought that S. Typhi estab-
lishes residence within an intracellular compartment (presum-
ably in the gall bladder) although the specific cell type(s) in which
it may reside has not been defined (House et al., 2001; Parry
et al., 2002). However, according to the model presented here,
it is possible that infected cells lacking receptors for the toxin
could provide a safe haven for the bacteria and at the same
time serve as a source of toxin that could act on other cells
and at systemic sites. Although the targets of the ADP-ribosylat-
ing activity of PltA are unknown, CDT through the action of its ac-
tive subunit CdtB, is known to hamper the activity of immune
cells (Lara-Tejero and Gala´n, 2002; Mooney et al., 2001; Shenker
et al., 1999). Therefore, the typhoid toxin activities, coupled to its
unique delivery mechanism, may be critical for S. Typhi to estab-
lish persistent infection in the human host and avoid immune
defenses.
More studies will be required to clarify the mechanisms of
toxin transport out of and into the cell, as well as to identify the
cellular machinery involved in these steps. However, our results
highlight the potentially dynamic nature of the S. Typhi-contain-
ing vacuole, which does not seem to remain isolated from other
cellular compartments but instead seems to be permissive for
the delivery of bacterial products to other cellular compartments.
In fact, such a dynamic behavior of a bacteria-containing vacu-
ole has been previously reported for Mycobacterium tuberculo-
sis, although in this case it was shown that bacterial lipids are
transported outside of the bacteria-containing phagosome
(Beatty et al., 2000). The dynamic nature of bacteria-containing
phagosomes may have important implications for the interaction
of intracellular microbial pathogens with the innate and acquired
immune systems.
EXPERIMENTAL PROCEDURES
Plasmids, Bacterial Strains, Media, and Growth Conditions
The wild-type Salmonella enterica serovar Typhi strain ISP2825 has been de-
scribed previously (Gala´n and Curtiss, 1991). Mutant strains carrying in-frame
deletions or insertion mutations in cdtB, pltA, or pltB strains expressing chro-
mosomally encoded 33-FLAG or 33-Myc tagged versions of these proteins or
carrying the transcriptional reporter fusion pltA::luc in the chromosome were
constructed by standard recombinant DNA and allelic exchange procedures
as previously described (Kaniga et al., 1994). The pltA and pltB complementing
plasmid was constructed by cloning a 1.6 kb DNA fragment comprising both
open reading frames and 500 bp upstream of pltB, which includes the
promoter region, in the BamHI site of the pACYC184 vector (Chang and
Cell Host & Microbe
Exotoxin Delivery by an Intracellular PathogenCohen, 1978). Plasmids expressing polyhistidine-tagged pltA, pltB, and cdtB
were constructed by cloning the PCR-amplified genes into the pQE-60 vector
(QIAGEN). pltAE133A, which carries a single amino acid substitution within its
catalytic site, was generated using the quick-change system (Stratagene) fol-
lowing the manufacturer’s instructions. S. Typhi strains were grown in LB broth
containing 0.3 M NaCl at 37C. When required, kanamycin (50 mg/ml), ampicil-
lin (100mg/ml), and chloramphenicol (20 mg/ml) were added.
Cell Culture, Bacterial Infections, and Toxicity Assays
Henle-407 intestinal epithelial cells were grown in DMEM supplemented with
10% bovine calf serum (BCS; HyClone). Overnight cultures of the different
S. Typhi strains were diluted 1/20 in LB broth containing 0.3 M NaCl and grown
until they reached an optical density measured at 600 nm (OD600) of 1.0. Cells
were infected with the different strains of S. Typhi at a multiplicity of infections
of 30 in HBSS. One and a half hours postinfection, cells were washed three
times with HBSS and incubated for 1 hr in DMEM supplemented with 10%
BCS and gentamicin (100 mg/ml) to kill extracellular bacteria. Cells were then
washed, and fresh DMEM containing BCS and 5 mg/ml gentamicine was
added to avoid cycles of reinfection. When appropriate, neutralizing or preim-
mune serum was added 4 hr after infection at a dilution of 1:50. Cells were
monitored for up to 3 days by phase-contrast microscopy for signs of toxicity
or were processed for cell-cycle analysis as previously described (Lara-Tejero
and Gala´n, 2000, 2001). Cell-cycle profiles were analyzed with Watson Prag-
matic algorithm in the FlowJo cytometry analysis software (Three Star, Inc.,
Ashland, OR).
Protein Secretion Assay
Protein secretion after bacterial infection was assayed as previously described
(Collazo and Gala´n, 1997). Briefly, approximately 107 cells were infected with
wild-type S. Typhi or its isogenic DpltA or DpltB mutants, all expressing a 33-
FLAG-tagged CdtB, and 24 hr after infection, cells were detached from the
plate by adding 30 mg/ml proteinase K and lysed in 0.3% Triton X-100 in
PBS. Lysates were centrifuged 5 min at 20,000 3 g, and the supernatants
were filtered through a 0.2 mm filter. Filtered supernatants (representing the se-
creted fraction) and pellets (representing the bacterially associated fraction)
were analyzed by western immunoblotting with an antibody directed to the
FLAG tag.
Luciferase Reporter Assay
Henle-407 cells were infected with the reporter strain of S. Typhi as indicated
above. At different times after infection, cells were washed and lysed in
Passive Lysis Buffer (Promega Dual-Luciferase Reporter Assay System) and
then sonicated. Firefly luciferase activity in lysates was measured using a lu-
minometer as recommended by the manufacturer (Promega). Cells processed
and infected in parallel in identical fashion were lysed with 0.1% deoxycholic
acid, and dilutions of lysates were plated onto LB agar plates to determine
the number of intracellular bacteria. Results were standardized based on the
number of cfu.
Immunofluorescence Analysis
Infected cells were fixed in 4% paraformaldehyde, treated with 3% BSA, 4%
goat serum, 0.3% Triton X-100, 50 mM NH4Cl in PBS, and labeled with the fol-
lowing primary antibodies: mouse monoclonal anti-FLAG M2 (Sigma; 1:10,000
dilution); rabbit polyclonal anti-Myc (Abcam; 1:2,000 dilution); and rabbit poly-
clonal anti-S. Typhi lipopolysaccharide (Difco Laboratories; 1:2,000 dilution),
affinity-purified rabbit antibody raised against recombinant CdtB/PltA/PltB
complex (2 mg/ml). Secondary anti-rabbit and anti-mouse antibody conjugated
to Alexa 488 or Alexa 594 were used at 1:2,000 dilution and 40,6-diamidino-2-
phenylindole (DAPI) was used at a concentration of 0.5 mg/ml. Images were ac-
quired with an inverted microscope (Eclipse TE2000-U; Nikon) equipped with
a CCD camera (MicroMAX RTE/CCD-1300Y; Princeton Instruments).
Protein Purification and Chromatography
Recombinant, polyhistidine-tagged PltA, PltB, or CdtB were expressed in
E. coli, purified from inclusion bodies using nickel-affinity chromatography un-
der denaturing conditions (8 M urea), and refolded together as previously
described (Akeda and Gala´n, 2004). Nonsoluble materials were removed by
centrifugation and filtration, and the resulting soluble proteins were used inthe different biological and chromatographic assays. The PltA-PltB complex
was purified using a Superdex 75 HR column (Amersham Pharmacia), equili-
brated with 30 mM Tris-HCl pH 8, 1 mM DTT, and 5% glycerol, and run with
a flow rate of 0.3 ml/min. To investigate the PltA/PltB/CdtB complex formation,
the MonoQ column (Amersham Pharmacia) was loaded with the refolded com-
plex (0.5 mg of each purified protein) (or CdtB alone) in a buffer containing
30 mM Tris-HCl pH 8.8, 1 mM DTT, and 5% glycerol. Proteins were eluted with
20 ml of a linear gradient of 0 to 500 mM NaCl in the same sample buffer at a
flow rate of 1 ml/min.
Antibody Production and Affinity Purification
The PltA/PltB/CdtB complex was purified on a Superdex 200 HR column
(Amersham Pharmacia) and used to immunize rabbits following standard pro-
cedures (Pocono Rabbit Farm and Laboratory, Canadensis, PA). For affinity
purification, the PltA/PltB/CdtB complex was bound to a HiTrap NHS-acti-
vated HP column (GE Healthcare), and the antibody was purified according
to the manufacturer’s instructions.
In Vitro ADP-Ribosylation Assay
Postnuclear supernatants from Henle-407 cells (50 mg) obtained by standard
procedures were incubated with purified recombinant PltA (1 mg) in a buffer
containing 30 mM Tris-HCl pH8, 1 mM DTT, and 50 mCi NAD-32P in a final vol-
ume of 25 ml. The reaction mix was incubated for 1 hr at 37C, stopped by heat
inactivation for 15 min at 70C, and trichloroacetic acid (TCA) was added to a fi-
nal concentration of 10% in a final volume of 200 ml. The precipitation mix was
incubated on ice for 1 hr, centrifuged, and washed three times with acetone.
The pellet was dried at room temperature, resuspended in loading buffer,
and submitted to SDS-PAGE. The gel was dried and exposed for autoradiog-
raphy.
Supplemental Data
The Supplemental Data include eight supplemental figures and can be found
with this article online at http://www.cellhostandmicrobe.com/cgi/content/
full/3/1/30/DC1/.
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